Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani on Q2 2021 Results – Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2021 Earnings Conference Call July 29, 2021 5:30 PM ET
Company Participants
Michael Partridge – SVP of IR
Reshma Kewalramani – CEO and President
Stuart Arbuckle – Chief Commercial and Operations Officer

Click here to view the original article.